Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pendyala

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Bacteriology|January 1, 1979
Nature of 6-methylpurine inhibition and characterization of two 6-methylpurine-resistant mutants of Neurospora crassaL Pendyala, J Smyth, A M Wellman
Urology|January 1, 1991
Pharmacokinetics and metabolism of nilutamideP J Creaven, L Pendyala, D Tremblay
Drugs Under Experimental and Clinical Research|January 1, 1986
Clinical development of iproplatin (CHIP)P J Creaven, L Pendyala, S Madajewicz
Cancer Research|November 1, 1985
Effect of renal function impairment of iproplatin pharmacokinetics and relation to toxicityL Pendyala, S Madajewicz, P J Creaven
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of 1-[2-[2-(4 pyridyl)-2-imidazolinyl-(1)]-ethyl]-3-(4-carboxyphenyl) urea (CGP 15720A)L Pendyala, S Madajewicz, P J Creaven
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1993
Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humansP J Creaven, L Pendyala, N J Petrelli
Cancer Chemotherapy and Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-deazaguanineL Pendyala, P J Creaven, L R Whitfield
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1993
Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trialL Pendyala, P J Creaven, C W Porter
Cancer Treatment Reports|March 1, 1982
Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dogL Pendyala, J W Cowens, P J Creaven
Canadian Journal of Biochemistry|May 1, 1980
Guanosine metabolism in Neurospora crassaW L Greer, L Pendyala, A M Wellman
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Bacteriology|January 1, 1979
Nature of 6-methylpurine inhibition and characterization of two 6-methylpurine-resistant mutants of Neurospora crassaL Pendyala, J Smyth, A M Wellman
Urology|January 1, 1991
Pharmacokinetics and metabolism of nilutamideP J Creaven, L Pendyala, D Tremblay
Drugs Under Experimental and Clinical Research|January 1, 1986
Clinical development of iproplatin (CHIP)P J Creaven, L Pendyala, S Madajewicz
Cancer Research|November 1, 1985
Effect of renal function impairment of iproplatin pharmacokinetics and relation to toxicityL Pendyala, S Madajewicz, P J Creaven
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of 1-[2-[2-(4 pyridyl)-2-imidazolinyl-(1)]-ethyl]-3-(4-carboxyphenyl) urea (CGP 15720A)L Pendyala, S Madajewicz, P J Creaven
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1993
Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humansP J Creaven, L Pendyala, N J Petrelli
Cancer Chemotherapy and Pharmacology|January 1, 1991
Clinical pharmacokinetics of 3-deazaguanineL Pendyala, P J Creaven, L R Whitfield
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 1, 1993
Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trialL Pendyala, P J Creaven, C W Porter
Cancer Treatment Reports|March 1, 1982
Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dogL Pendyala, J W Cowens, P J Creaven
Canadian Journal of Biochemistry|May 1, 1980
Guanosine metabolism in Neurospora crassaW L Greer, L Pendyala, A M Wellman
Pageof 6